Valganciclovir Tablets recalled over temperature-control failures
- Recall date
- February 13, 2018
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Hetero Labs Limited Unit V recalls Valganciclovir Tablets, USP, 450 mg, 60-count bottle, Rx Only, Manufactured for Camber Pharmaceuticals, Inc. Piscataway…
- Recall number
- D-0601-2018
- FDA classification
- Class II
- Brand / firm
- Hetero Labs Limited Unit V
- Sold / distributed
- NJ and then distributed Nationwide in the USA
Why it was recalled
Temperature Abuse: Valganciclovir Tablets USP 450 mg and Valacyclovir Tablets USP 1 gram were exposed to higher temperature at airport or cargo and in the same consignment of Famciclovir complaint batch (D-0415-2018).
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Valganciclovir Tablets, USP, 450 mg, 60-count bottle, Rx Only, Manufactured for Camber Pharmaceuticals, Inc. Piscataway, NJ 08854, By: Hetero Hetero Labs Limit Unit V Pollypally Jadcherla Mahaboob Nagar - 509 301 India. NDC # 31722-832-60
Get recall alerts
Free email alert whenever Hetero Labs Limited Unit V has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Hetero Labs Limited Unit V